Skip to main content
Equibles

UBS Group AG

Position in PRQR — ProQR Therapeutics N.V.

CIK 1610520 ZURICH, V8
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,188,991
+$694,464 QoQ
Shares Held
639,243
+109.4% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 69 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. PRQR ranks #256 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in PRQR

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,188,991 639,243
2026-03-31 $494,527 305,264
2025-12-31 $1,611,280 797,664
2025-09-30 $201,391 94,550
2025-06-30 $2,333,422 1,143,835
2025-03-31 $2,376,774 1,787,049
2024-12-31 $6,121,631 2,310,050
2024-09-30 $5,278 2,900
2024-06-30 $45,726 27,546
2024-03-31 $11,381 4,970
2023-12-31 $7,722 3,900
2023-09-30 $13,057 10,044
2023-06-30 $7,583 4,681
2023-03-31 $7,668 3,600
2022-12-31 $10,892 2,944
2022-09-30 $3,792 5,098
2021-12-31 $675,459 84,327
2021-09-30 $787,750 94,116
2021-06-30 $417,967 62,013
2021-03-31 $598,965 90,615
2020-12-31 $1,982,832 472,103
2020-09-30 $2,291,176 478,325
2020-06-30 $2,932,177 482,266
2020-03-31 $2,649,523 482,609